DK1328273T3 - Anordning og fremgangsmåder til transdermal indgivelse af felodipin - Google Patents

Anordning og fremgangsmåder til transdermal indgivelse af felodipin

Info

Publication number
DK1328273T3
DK1328273T3 DK01988573T DK01988573T DK1328273T3 DK 1328273 T3 DK1328273 T3 DK 1328273T3 DK 01988573 T DK01988573 T DK 01988573T DK 01988573 T DK01988573 T DK 01988573T DK 1328273 T3 DK1328273 T3 DK 1328273T3
Authority
DK
Denmark
Prior art keywords
felodipine
methods
transdermal administration
skin
days
Prior art date
Application number
DK01988573T
Other languages
Danish (da)
English (en)
Inventor
Mark Alfonso
Geraldine Marcenyac
Lino Tavares
Ihor Shevchuk
Kirti H Valia
Original Assignee
Euro Celtique Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Euro Celtique Sa filed Critical Euro Celtique Sa
Application granted granted Critical
Publication of DK1328273T3 publication Critical patent/DK1328273T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061—Polyacrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4422—1,4-Dihydropyridines, e.g. nifedipine, nicardipine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7069—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained otherwise than by reactions only involving carbon to carbon unsaturated bonds, e.g. polysiloxane, polyesters, polyurethane, polyethylene oxide

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
DK01988573T 2000-10-23 2001-10-23 Anordning og fremgangsmåder til transdermal indgivelse af felodipin DK1328273T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US24251400P 2000-10-23 2000-10-23
PCT/US2001/049950 WO2002034206A2 (en) 2000-10-23 2001-10-23 Felodipine transdermal device and methods

Publications (1)

Publication Number Publication Date
DK1328273T3 true DK1328273T3 (da) 2008-10-20

Family

ID=22915068

Family Applications (1)

Application Number Title Priority Date Filing Date
DK01988573T DK1328273T3 (da) 2000-10-23 2001-10-23 Anordning og fremgangsmåder til transdermal indgivelse af felodipin

Country Status (9)

Country Link
EP (1) EP1328273B1 (pt)
AT (1) ATE399551T1 (pt)
AU (1) AU2002232755A1 (pt)
CY (1) CY1108368T1 (pt)
DE (1) DE60134656D1 (pt)
DK (1) DK1328273T3 (pt)
ES (1) ES2309107T3 (pt)
PT (1) PT1328273E (pt)
WO (1) WO2002034206A2 (pt)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10305137A1 (de) * 2003-02-07 2004-08-26 Novosis Ag Transdermale therapeutische Abgabesysteme mit einem Butenolid
AU2005204391A1 (en) * 2004-01-14 2005-07-28 Lavipharm Laboratories, Inc. Transdermal delivery device for dihydropyridine type calcium antagonists containing at least one fatty acid

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1993010781A1 (en) * 1991-12-02 1993-06-10 Sepracor, Inc. Methods and compositions for treating hypertension, angina, and other disorders using optically pure s(-) felodipine
US5882676A (en) * 1995-05-26 1999-03-16 Alza Corporation Skin permeation enhancer compositions using acyl lactylates
US5968547A (en) * 1997-02-24 1999-10-19 Euro-Celtique, S.A. Method of providing sustained analgesia with buprenorphine
WO2000045797A1 (en) * 1999-02-02 2000-08-10 Ortho-Mcneil Pharmaceutical, Inc. Method of manufacture for transdermal matrices

Also Published As

Publication number Publication date
EP1328273A2 (en) 2003-07-23
WO2002034206A9 (en) 2003-04-17
PT1328273E (pt) 2008-09-23
WO2002034206A2 (en) 2002-05-02
EP1328273A4 (en) 2004-09-22
ATE399551T1 (de) 2008-07-15
WO2002034206A3 (en) 2002-07-18
EP1328273B1 (en) 2008-07-02
ES2309107T3 (es) 2008-12-16
AU2002232755A1 (en) 2002-05-06
DE60134656D1 (de) 2008-08-14
CY1108368T1 (el) 2014-02-12

Similar Documents

Publication Publication Date Title
DK1316308T3 (da) Transdermalt terapeutisk plaster med capsaicin og capsaicin-analoger
DE69613840D1 (de) Orale dosierungsform und verfahren zur behandlung von schmerzzuständen in dermundhöhle
DK0443007T3 (da) Udvortes analgetisk lotion og fremgangsmåde til fremstilling heraf
NO20063373L (no) CD40-antistoff-formuleringer og fremgangsmater
DE60115842D1 (de) Ventilanordnung
CY1107452T1 (el) Διαδερμικη μορφη χορηγησης για τη θεραπεια του συνδρομου ανησυχων ποδιων
DK0500847T3 (da) Behandling af obesitas med en alfa-2-adrenergisk agonist og et væksthormonfrigørende peptid
ATE400258T1 (de) Transdermales buprenorphin-dosierschema zwecks schmerzstillung
DK0817646T3 (da) Fremgangsmåder til behandling af inflammation og præparater derfor
DK1328273T3 (da) Anordning og fremgangsmåder til transdermal indgivelse af felodipin
DK1638492T3 (da) Præoperativ behandling af postoperativ smerte
WO2002054996A3 (en) Terazosin transdermal device and methods
DK1063978T3 (da) Fremgangsmåde til behandling af neuromsmerter
ATE247965T1 (de) Paracetamol und buspiron enthaltende pharmazeutische zusammensetzung mit analgetischer wirkung
WO1997026880A3 (en) Use of a combination of delavirdine and one or more protease inhibitors in hiv-1 infected patients
DE69734349D1 (de) Behandlung von knochenleiden mit adrenomedullin
AR020815A1 (es) Procedimiento para el tratamiento de la esquizofrenia, como tambien medios para ser utilizados en dicho procedimiento
DK1007085T3 (da) Anvendelse af væksthormon i præparater til behandling af insulin-resistens i hjertet
DK1137420T3 (da) Anvendelse af en kombination af et purin og en nitrogenmonooxiddonor til forebyggelse eller behandling af sexuel dysfunktion
DE60130253D1 (de) Zusammensetzungen zur verhinderung der adhäsion
NO20022187D0 (no) Fremgangsmåte for behandling og forebygging av neurodegenerative forstyrrelser
NO960866L (no) Fremgangsmåte til behandling av leversykdom og lignende indikasjoner med vasodilaterende midler
MD1469G2 (ro) Metodă de tratament al şocului combustional
SE9802555D0 (sv) New pharmaceutical preparation and method
UA39708A (uk) Спосіб лікування хворих з післяампутаційним больовим синдромом